Physician

Nadine Aboul-Magd, M.D.

According to 2025 Medicare claims, Nadine Aboul-Magd, M.D. (NPI: 1083930648) practices nephrology in the Joplin, MO-KS market, with the plurality of this provider's patient population coming from Jasper, MO. This provider's primary affiliated billing organization is AHMED ABOUL-MAGD PC (NPI: 1588678916; TIN: 050604077) and primary practice location at 64804-4524. Aboul-Magd is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616) and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Aboul-Magd's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 2,377 HCPCS/CPT codes, and received $227,419 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,508 prescription claims across 243 beneficiaries totaling $334,190 in drug costs, led by Auryxia (Ferric Citrate). DME data shows 76 claims. Open Payments data shows 29 records totaling $532. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $41,622 and ending at $227,419. Concurrently, Part D prescription costs have risen steadily, from $23,065 to $334,190. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	172	411	$41,622
2016	351	1,734	$148,280
2017	582	2,672	$231,943
2018	502	2,503	$224,317
2019	592	3,056	$301,141
2020	464	2,216	$232,792
2021	369	1,864	$195,479
2022	389	1,726	$178,798
2023	387	2,166	$224,713
2024	424	2,377	$227,419

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	75	$23,065
2016	84	390	$126,232
2017	122	745	$284,033
2018	166	900	$203,889
2019	181	1,185	$136,211
2020	195	1,253	$217,075
2021	193	1,025	$200,619
2022	228	1,088	$233,765
2023	248	1,479	$450,055
2024	243	1,508	$334,190

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	16	$229
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	49	$1,080
2024	N/R	76	$1,282

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	124	165	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	175	312	$84
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	176	623	$62
90935	Hemodialysis procedure with physician evaluation	73	197	$56
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	183	316	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Auryxia	Ferric Citrate	18	1,260	$62,313
Velphoro	Sucroferric Oxyhydroxide	22	660	$58,654
Farxiga	Dapagliflozin Propanediol	52	2,312	$44,462
Veltassa	Patiromer Calcium Sorbitex	18	1,187	$31,080
Lokelma	Sodium Zirconium Cyclosilicate	20	906	$21,268

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	12	$489
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	26	$319
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$245
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	13	$222
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	11	$8

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$532	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nadine Aboul-Magd, M.D.?

Tedicare shows public-source Medicare data for Nadine Aboul-Magd, M.D. (NPI 1083930648), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nadine Aboul-Magd, M.D. have ACO affiliation data?

Nadine Aboul-Magd, M.D. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616) and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Nadine Aboul-Magd, M.D.?

Nadine Aboul-Magd, M.D. is linked to AHMED ABOUL-MAGD PC (billing NPI 1588678916) in the available physician profile data.

Does Nadine Aboul-Magd, M.D. have Open Payments data?

Nadine Aboul-Magd, M.D. has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.